Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier Proceedings of a Workshop (2018) / Chapter Skim
Currently Skimming:
Appendix C: Registered Attendees
Appendix C: Registered Attendees
Pages 51-60
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 51... ...
52 TRAVERSING THE BLOOD–BRAIN BARRIER C Registered Attendees Neeraj Agarwal Abdulai Barrie National Eye Institute Department of Chemical and Biological Sciences, Diaa Ahmed Montgomery College, Helway University Germantown, Maryland Mark Allegretta Isle Bastille National Multiple Sclerosis Harvard Medical School Society William Beckett Susan Amara William Beckett & Associates National Institute of Mental Health Virginia Berry Amgen Forest Andrews Eli Lilly and Company Julia Berzhanskaya National Institutes of Health Shelli Avenevoli National Institute of Mental Ruben Boado Health ArmaGen Frank Avenilla Karen Boisvert National Institute of Mental AbbVie Inc. Health Lizbet Boroughs David Banach Association of American AbbVie, Inc.
|
From page 52... ...
Antonio Chiocca GE Global Research Harvard Medical School Gregory Busse Choi-Fong Cho Takeda Pharmaceuticals Brigham and Women's Hospital, Harvard Medical Grant Campany School XPRIZE Foundation Jennifer Cosenza Rosa Canet-Aviles Feinstein Kean Healthcare Foundation for the National Institutes of Health Johnny Croy Eli Lilly and Company Mark Carol Sonacare Medical Kangwen Deng AbbVie Inc. Randall Carter GE Global Research Dario Doller Sage Therapeutics Martin Case Janssen Research & Xavier du Maine Development, LLC Harvard Medical School Balu Chakravarthy Lee Dudka National Research Council of Dudka & Associates Canada Martin A
|
From page 53... ...
APPENDIX C 53 Emmeline Edwards Robert Greely National Center for Biogen Complementary and Integrative Health Shenita-Ann Grymes BrittNelle Health Services Adam Fleisher Group, LLC Eli Lilly and Company Chenghua Gu Thomas Forbes Harvard Medical School Children's National Health System Sean Han Amgen Peter Frinking Bracco Joseph Hanig Food and Drug Allyson Gage Administration Cohen Veterans Bioscience Richard Hatzfeld Lei Gao Feinstein Kean Healthcare, an AbbVie Inc. Ogilvy Company Hugo Geerts Ramona Hicks In Silico Biosciences One Mind Reza Ghodssi Stuart Hoffman University of Maryland Office of Research and Development, Department Alexandra Golby of Veterans Affairs Harvard Medical School, Brigham and Women's Douglas Hunt Hospital, Department of ArmaGen Neurosurgery Steven Hyman Marjorie Gondre-Lewis Stanley Center for Psychiatric Howard University College of Research Medicine Michael Irizarry Viviana Gradinaru Eli Lilly and Company California Institute of Technology
|
From page 54... ...
Lisanby Eshelman School of National Institute of Mental Pharmacy Health Claire Kaplan Roger Little University of Maryland National Institute on Drug College Park Abuse Kristin Kemmerich Linda Loyd National Research Council of Ippfast Inc. Canada Lucy Lu Alireza Khaligh Merck University of Maryland Yifeng Lu Sooja Kim AbbVie Inc.
|
From page 55... ...
Amgen PH RockWood LLC Nikunj Patel Radha Murthy Food and Drug Nimhans Administration Dylan Neel Vikram Patel Harvard University Food and Drug Administration Jorge L Nina Espinosa University of Puerto Rico
|
From page 56... ...
Texas A&M University Shilpa Sambashivan Ipolia Ramadan Amgen National Institutes of Health Ahmed Samir Deepa Rao Charite Berlin Food and Drug Administration
|
From page 57... ...
APPENDIX C 57 Eric Schaeffer Krystyna Solarana Janssen Research & Food and Drug Development, LLC Administration Eugenia Schenecker Andrew Sostek The George Washington Katanya University Barry Springer Oliver Schmidt Janssen Research & Eli Lilly and Company Development, LLC Ralf Seip Stinivasa Srinivasa Sonacare Medical National Institute of Mental Health and Neuro-Sciences, Masha Sergeeva Bangalore, India DMPK4BIOTECH Danica Stanimirovic Lisa Shafer National Research Council of Teva Pharmaceuticals Canada Dhavalkumar Shah Pawel Stocki University of New York at Ossianix, Inc. Buffalo, Department of Pharmaceutical Sciences Bernd Stowasser Sanofi Lily Silayeva Defense Threat Reduction Jennifer Stratton Agency Teva Pharmaceuticals Len Singer Ron Swanson Smarterage LLC Janssen Research & Development, LLC Sanjaya Singh Janssen Pharmaceutical Edmund Talley Companies of Johnson & National Institute of Johnson Neurological Disorders and Stroke/BRAIN Initiative Patroula Smpokou Department of Health and Human Services
|
From page 58... ...
Alan Trachtenberg Food and Drug Dionna Williams Administration Johns Hopkins University Kathleen Tusaie Dan Wolak William Beckett & Associates Amgen Rebecca Voelker Winifred Wu Journal of the American Strategic Regulatory Partners, Medical Association LLC
|
From page 59... ...
APPENDIX C 59 Shuyan Yi Amgen Nathan Yoganathan KalGene Pharmaceuticals Inc. Claudia Zamora Zamora Consulting Group Mark Zervas Amgen Berislav Zlokovic University of Southern California
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.